Audit 347000

FY End
2024-06-30
Total Expended
$7.10M
Findings
0
Programs
7
Organization: Erlanger Health System (TN)
Year: 2024 Accepted: 2025-03-20
Auditor: Pya PC

Organization Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
D8EALVM55NQ5 Lynn Dejaco Auditee
4237784789 Matt Stuart Auditor
No contacts on file

Notes to SEFA

Title: NOTE A--BASIS OF PRESENTATION Accounting Policies: The accompanying schedule of expenditures of federal awards and schedule of expenditures of state and other financial assistance include the grant activity of Erlanger Health and are presented on the accrual basis of accounting. The information in these schedules is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) and the Tennessee Comptroller of the Treasury, respectively. Therefore, some amounts presented in these schedules may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. De Minimis Rate Used: N Rate Explanation: Erlanger Health has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards and schedule of expenditures of state and other financial assistance include the grant activity of Erlanger Health and are presented on the accrual basis of accounting. The information in these schedules is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) and the Tennessee Comptroller of the Treasury, respectively. Therefore, some amounts presented in these schedules may differ from amounts presented in, or used in the preparation of, the consolidated financial statements.
Title: NOTE B--SIGNIFICANT ACCOUNTING POLICIES Accounting Policies: The accompanying schedule of expenditures of federal awards and schedule of expenditures of state and other financial assistance include the grant activity of Erlanger Health and are presented on the accrual basis of accounting. The information in these schedules is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) and the Tennessee Comptroller of the Treasury, respectively. Therefore, some amounts presented in these schedules may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. De Minimis Rate Used: N Rate Explanation: Erlanger Health has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. DeMinimis Indirect Cost Rate: Erlanger Health has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.
Title: NOTE C--CONTINGENCIES Accounting Policies: The accompanying schedule of expenditures of federal awards and schedule of expenditures of state and other financial assistance include the grant activity of Erlanger Health and are presented on the accrual basis of accounting. The information in these schedules is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) and the Tennessee Comptroller of the Treasury, respectively. Therefore, some amounts presented in these schedules may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. De Minimis Rate Used: N Rate Explanation: Erlanger Health has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. Erlanger Health's federal programs are subject to financial and compliance audits by grantor agencies which, if instances of material noncompliance are found, may result in disallowed expenditures and affect Erlanger Health's continued participation in specific programs. The amount, if any, of expenditures which may be disallowed by the grantor agencies cannot be determined at this time, although Erlanger Health expects such amounts, if any, to be immaterial.